Vineti

Orchestrating personalized cell & gene therapy treatments for cancers & rare diseases

Principal Product Designer

2016-2022 | San Francisco, then nomadic

⊕

Orchestrating personalized cell & gene therapy treatments for cancers & rare diseases

Vineti was founded to solve the key challenges faced by patients, medical providers, pharmaceutical companies, and regulators in the delivery and commercialization of personalized medicine. Over six years, Vineti became the proven clinical-to-commercial platform for cell & gene therapy supply chain management.

Role. From the ground up, I researched, designed, prototyped, expanded and scaled the configurable, cross-channel patient treatment logistics platform. Worked with balanced teams and mentored growing design team throughout.

Cell & Gene Therapy

Cell & gene therapies (CGT) are biologic drugs manufactured using the cells (blood or tissue) of a patient. They involve some of the most complex workflows in medicine, and require careful tracking across a series of locations.

Solution

Vineti built a platform for clinical and commercial cell & gene therapy supply chain management. The Dominos Pizza TrackerTM for cell therapies, if you will.

Impact

Vineti’s platform supported therapies across 26 disease indications, delivering treatments to ~5,000 patients before exit.

5k patient treatments delivered 16 pharma company customers 26 disease indications

Exit

Software acquired by Johnson & Johnson to continue supporting their global commercial therapy rollouts and ongoing clinical trials.

Team

Role

From the ground up, researched, designed, prototyped, expanded and scaled the configurable, cross-channel patient treatment logistics platform. Worked with balanced teams and mentored growing design team throughout.